OS Therapies Incorporated (OSTX)
NYSE: OSTX · Pharmaceutical Preparations · Rockville, MD · filing with the SEC since 2019
Who runs OS Therapies Incorporated
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Romness Paul A.
President and CEO. First filing Aug 2024, latest Oct 30, 2026, 0 filings in all.
Officers reporting now
5
of 11 people with a filing in the last fifteen months
Directors reporting now
6
13 people on the record since 2024
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Francis Knuettel II | Chief Financial Officer | Oct 2026 | Nov 12, 2026 | none |
| Clem Kerry M | Chief Commercial Officer | Oct 2026 | Nov 12, 2026 | none |
| Romness Paul A. | President and CEO | Aug 2024 | Oct 30, 2026 | none |
| Petit Robert | See Remarks | Aug 2024 | Oct 30, 2026 | none |
| Acevedo Christopher P. | Chief Financial Officer | Aug 2024 | Feb 13, 2026 | none |
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Ciccio John | director | Aug 2024 | Oct 30, 2026 | none |
| Eagle Craig | director | Jul 2026 | Oct 30, 2026 | none |
| Jarry Olivier Roger | director | Oct 2024 | Oct 30, 2026 | none |
| Mckean-Dieser Avril Suzette | director | Oct 2024 | Oct 30, 2026 | none |
| Search Theodore F. | director | Aug 2024 | Oct 30, 2026 | none |
| Galzahr Karim | director | Feb 2025 | Feb 13, 2026 | none |
Earlier names on the record4, newest filing first
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.